Investment
Neva II Fund joined Nouscom's EUR 120M Series D for cancer interception immunotherapy.
Nouscom
OCT 19, 2026
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Nouscom
Neva SGR event at OGR Torino
Straiker
Phosphorus
Commonwealth Fusion Systems